DOVER, Delaware, Sept. 24, 2019 /PRNewswire/ — CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Fenestrated Pedicle Screw System used in the treatment of patients with advanced stage spinal tumors. CarboClear® Fenestrated Pedicle Screws are used in conjunction with a high viscosity, radiopaque, PMMA bone cement (Teknimed’s High V+ …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone